Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion type Assertion NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_head.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion evidence source_evidence_literature NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion SIO_000772 23308200 NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion wasDerivedFrom befree-20150227 NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.
- NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_assertion wasGeneratedBy ECO_0000203 NP369490.RAGNm5FJQhHaR3-Id_tLzolR7umbsfGkdZgN7CeOP-K-A130_provenance.